Concepedia

Sarit Cohen‐Rabbie

SC

Statistics

Publications

4

Citations

56

H-Index

4

Active since

2021

Affiliations

AstraZeneca (South Korea)(Current)

AstraZeneca (United Kingdom)

AstraZeneca (Singapore)

AstraZeneca (Australia)

AstraZeneca (Poland)

Sarit Cohen‐Rabbie is an author at AstraZeneca (South Korea) specializing in pharmacology, neurofibromatosis-associated tumors, and clinical pharmacology.

Publications per year

2021–2022

4

Publications

4

Population pharmacokinetics and exposure–response of selumetinib and its N‐desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas

Stein Schalkwijk, Li Zhou, Sarit Cohen‐Rabbie et al. · Cancer Chemotherapy and Pharmacology · 2021 · 16 citations

, , +15

QT Prolongation Risk Assessment in Oncology: Lessons Learned From Small‐Molecule New Drug Applications Approved During 2011‐2019

Sarit Cohen‐Rabbie, Aliénor Berges, Dinko Rekić et al. · The Journal of Clinical Pharmacology · 2021 · 15 citations

, , +11

Physiologically Based Pharmacokinetic Modeling for Selumetinib to Evaluate Drug‐Drug Interactions and Pediatric Dose Regimens

Sarit Cohen‐Rabbie, Li Zhou, Karthick Vishwanathan et al. · The Journal of Clinical Pharmacology · 2021 · 15 citations · Full text

, , +17

Effect of food on capsule and granule formulations of selumetinib

Sarit Cohen‐Rabbie, Alexandra Mattinson, Karen So et al. · Clinical and Translational Science · 2022 · 10 citations · Full text

, , +17

1–4 of 4